AdipoPharma
PrivateLast Round
Series A
Jan 23, 2023
Momentum
Top 25%
of companies Caplight tracks
Company Overview
AdipoPharma operates in Healthcare & Life Sciences and is based in Strasbourg. Its latest recorded funding round was a Series A round in January 2023.
AdipoPharma is a biotechnology company that develops peptide-based therapeutic treatments for insulin resistance and Type 2 diabetes.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AdipoPharma Comparables
Compare AdipoPharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Adipo Therapeutics | 81% | |
| Antag Therapeutics | 81% | |
| OrsoBio | 77% |
For institutional investors. Book with your work email.
AdipoPharma Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
AdipoPharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Good Growth Capital | Series A |
| Okeanos | Series A |
| ORSA | Series A |
| Sambrinvest | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors grew 474% MoM, from 399 to 2.3K.
- Apr 6, 2026
Monthly visitors increased 67% MoM.
For institutional investors. Book with your work email.
AdipoPharma Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about AdipoPharma's valuation, stock price, and market status.
Is AdipoPharma a public or private company?
AdipoPharma is a private company.
What is the current stock price of AdipoPharma?
AdipoPharma is a private company, so its shares have no public market price. Caplight tracks AdipoPharma's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is AdipoPharma worth (valuation)?
Valuation information for AdipoPharma is not publicly available.
Can I buy AdipoPharma stock?
AdipoPharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was AdipoPharma's last funding round?
AdipoPharma's most recent funding round was Series A on January 23, 2023.
Who are the main investors in AdipoPharma?
Key investors in AdipoPharma include Good Growth Capital, Okeanos, ORSA, Sambrinvest.
Will AdipoPharma IPO soon?
No public IPO plans have been announced for AdipoPharma.
How can I track AdipoPharma secondary market activity?
Caplight tracks bids, offers, and trades in AdipoPharma's shares on secondary markets.